miércoles, 19 de noviembre de 2025

FDA approves epcoritamab-bysp for follicular lymphoma indications

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-epcoritamab-bysp-follicular-lymphoma-indications?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario